# FDA 483 - Radix Laboratories Inc - July 25, 2019

Source: https://www.globalkeysolutions.net/records/483/radix-laboratories-inc/d0e62ba8-a3ed-4710-b3c4-53719321cbb7

> FDA 483 for Radix Laboratories Inc on July 25, 2019. Product: veterinary. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Radix Laboratories Inc
- Inspection Date: 2019-07-25
- Product Type: veterinary
- Office Name: Minneapolis District Office
- Summary: Radix Laboratories Inc, an animal drug manufacturer in Eau Claire, WI, was cited for significant deficiencies during an FDA inspection. Observations included releasing drug products before complete testing, failing to follow procedures to prevent objectionable microorganisms in non-sterile products, and inadequate quality control unit procedures regarding document control. These issues indicate a lack of adherence to quality assurance and manufacturing process controls.

## Related Documents

- [483 - 2025-06-27](https://www.globalkeysolutions.net/records/483/radix-laboratories-inc/7221aee2-84b8-4051-9246-8f2e0c5c16e8)

## Related Officers

- [Deputy Commissioner for Foods](https://www.globalkeysolutions.net/people/james-k-ireland/78658286-3e62-4069-a8e1-b157aa77c7fe)

Company: https://www.globalkeysolutions.net/companies/radix-laboratories-inc/f98757c9-6117-4685-bef4-b92ce9d0f007

Office: https://www.globalkeysolutions.net/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
